Opportunity Growing For Newer Therapies In Emerging Markets
This article was originally published in PharmAsia News
Big pharmaceutical firms seeking to expand sales more aggressively in emerging markets should not underestimate the need for innovative therapies, specifically antiretrovirals, despite strong sales of generic medicines
You may also be interested in...
Situated in one of the globe's most active emerging markets, the Turkish pharmaceutical industry is undergoing fast changes, which could make or break major drug makers, according to Istanbul-based international consulting firm Egon Zehnder International
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).